Over 41,000 bottles of Walgreens nasal spray sit on pharmacy shelves nationwide with a dangerous bacterial contamination that could harm your family’s health.
At a Glance
FDA issues Class II recall for 41,328 bottles of Walgreens Saline Nasal Spray with Xylitol due to pseudomonas lactis contamination.
Two affected lot numbers with expiration dates extending into 2027 require immediate consumer action.
Walgreens offering full refunds for contaminated products at all locations nationwide.
Authorities have not disclosed how the bacterial contamination occurred in the manufacturing process.
Consumers should discontinue use immediately and return affected bottles for replacement or reimbursement.
Major Contamination Affects Nationwide Supply
In November 2025, the FDA announced a significant recall targeting 41,328 bottles of Walgreens Saline Nasal Spray with Xylitol distributed across the country. The contamination involves pseudomonas lactis, a bacterium commonly found in raw milk. This discovery prompted immediate action to protect consumers who rely on over-the-counter nasal relief products during cold and flu season.
💊 CHECK YOUR CABINET: The FDA announced a recall of 41,000+ bottles of Walgreens Saline Nasal Spray with Xylitol over possible bacterial contamination.https://t.co/vHsbLtvj3F
The affected product is the 1.5-ounce bottle of Walgreens Saline Nasal Spray with Xylitol. Two lot numbers require consumer attention: Lot No. 71409 expiring February 28, 2027, and Lot No. 71861 expiring August 31, 2027. These products were distributed to Walgreens locations nationwide, meaning millions of households may have purchased contaminated batches. Consumers should check their medicine cabinets immediately for these specific lot numbers before using the product.
FDA Classification and Health Risk Assessment
The FDA classified this recall as Class II, the second-highest risk level, indicating potential for temporary or medically reversible adverse health consequences. The agency emphasized this was a voluntary recall initiated by Walgreens’ supplier under FDA guidance. Class II recalls address situations where serious adverse health consequences are remote but exposure remains a concern warranting swift action to prevent widespread illness among vulnerable populations.
Consumer Response and Refund Process
Walgreens responded swiftly, issuing a statement emphasizing that customer safety remains the top priority. The company confirmed that consumers with affected products should not use them and should return bottles to any Walgreens location for full refunds. This straightforward process ensures families can obtain replacement products or reimbursement without delay, protecting household budgets during the busy holiday season.
Manufacturing Transparency Concerns
Notably, authorities have not disclosed how pseudomonas lactis contamination occurred during manufacturing. This lack of transparency raises questions about quality control procedures and supplier oversight. Consumers deserve clear explanations about how bacterial contamination reached store shelves and what preventive measures manufacturers implemented to prevent future incidents affecting public health and consumer trust.
Families should act immediately to check their nasal spray bottles and return any affected products. Protecting household health during cold and flu season requires vigilance, and this recall demonstrates the importance of staying informed about product safety notices affecting everyday items in your home.
